Sarah Speight
Key details
- Title: Senior Writer
- Email:sspeight@lifesciencesipreview.com
- Telephone: +44 (0)20 330 18210
Total results: 187
Articles by Sarah Speight
Pharma
The scientist-turned IP specialist chats to LSIPR about why she ‘loves’ the IP sector, her views on policy and funding in science and research, and the cases she’s most proud of. 13 October 2022
Europe
European Commission says pharma firm blocked generics over blockbuster MS drug| Teva “engaged in abusive conduct” to “artificially prolong the exclusivity” of Copaxone | Teva could be found to have infringed Article 102 of TFEU. 11 October 2022
Biotech
New partner specialises in chemical-related tech | USPTO-registered litigator is also certified licensing professional | Appointment follows several hires in firm’s patents department. 29 September 2022
Pharma
New partner brings pharma and chemistry focus, and boosts the European firm’s Unified Patent Court team. 1 September 2022
Pharma
Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided. 25 August 2022
article
Firm appoints new partner with ‘extensive’ in-house and experience | Move follows key office move to Colorado where life sciences sector ‘flourishing’. 23 August 2022
article
US senator lays into big pharma over ‘Republican-enabled’ tax schemes | Patents for cancer treatment Keytruda allegedly moved offshore. 28 July 2022
Pharma
Global industry body launches declaration | Poorer nations could benefit from more equitable vaccine access | Proposal to be tabled among G7 and G20. 21 July 2022
Americas
New partner boosts firm’s biotech practice | Move forms part of life sciences expansion | Role based at Washington, DC office. 19 July 2022
Americas
Licensing partners aim to prevent the introduction of a proposed eye drop generic treatment before the expiration of four patents. 5 July 2022
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.